Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (301-310 of 599) with videos related to

Pageof 60
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptorDilip K Tosh, Silvia Paoletta, Zhoumou Chen, et al.
Purinergic Signalling|March 6, 2014
The role of activated adenosine receptors in degranulation of human LAD2 mast cellsChi Ting Leung, Ang Li, Juni Banerjee, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 21, 2012
Controlling murine and rat chronic pain through A3 adenosine receptor activationZhoumou Chen, Kali Janes, Collin Chen, et al.
Bioconjugate Chemistry|December 20, 2011
Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognitionDilip K Tosh, Khai Phan, Francesca Deflorian, et al.
Anesthesiology|July 24, 2008
Lung injury after in vivo reperfusion: outcome at 27 hours after reperfusionIdit Matot, Sharon Einav, Carolyn F Weiniger, et al.
Thrombosis and Haemostasis|May 26, 2012
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregationCarl Högberg, Olof Gidlöf, Francesca Deflorian, et al.
Purinergic Signalling|March 25, 2024
Machine learning-aided search for ligands of P2Y<sub>6</sub> and other P2Y receptorsAna C Puhl, Sarah A Lewicki, Zhan-Guo Gao, et al.
Biochemical Pharmacology|November 18, 2009
Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptorJohn A Auchampach, Elizabeth T Gizewski, Tina C Wan, et al.
Journal of Medicinal Chemistry|July 26, 2002
Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonistsChrista E Müller, Mark Thorand, Ramatullah Qurishi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 9, 2019
Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation InhibitorsBarbara Cacciari, Pamela Crepaldi, Chun Yan Cheng, et al.
Pageof 60

Showing results (301-310 of 599) with videos related to

Sort By:
Pageof 60
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptorDilip K Tosh, Silvia Paoletta, Zhoumou Chen, et al.
Purinergic Signalling|March 6, 2014
The role of activated adenosine receptors in degranulation of human LAD2 mast cellsChi Ting Leung, Ang Li, Juni Banerjee, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 21, 2012
Controlling murine and rat chronic pain through A3 adenosine receptor activationZhoumou Chen, Kali Janes, Collin Chen, et al.
Bioconjugate Chemistry|December 20, 2011
Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognitionDilip K Tosh, Khai Phan, Francesca Deflorian, et al.
Anesthesiology|July 24, 2008
Lung injury after in vivo reperfusion: outcome at 27 hours after reperfusionIdit Matot, Sharon Einav, Carolyn F Weiniger, et al.
Thrombosis and Haemostasis|May 26, 2012
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregationCarl Högberg, Olof Gidlöf, Francesca Deflorian, et al.
Purinergic Signalling|March 25, 2024
Machine learning-aided search for ligands of P2Y<sub>6</sub> and other P2Y receptorsAna C Puhl, Sarah A Lewicki, Zhan-Guo Gao, et al.
Biochemical Pharmacology|November 18, 2009
Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptorJohn A Auchampach, Elizabeth T Gizewski, Tina C Wan, et al.
Journal of Medicinal Chemistry|July 26, 2002
Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonistsChrista E Müller, Mark Thorand, Ramatullah Qurishi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 9, 2019
Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation InhibitorsBarbara Cacciari, Pamela Crepaldi, Chun Yan Cheng, et al.
Pageof 60